PhD in Bioprocess Chemistry: Therapeutic Nucleoside Editing

The University of Manchester’s School of Chemistry invites applications for a fully funded PhD studentship in Bioprocess: Skeletal Editing of Therapeutic Nucleosides.

This 3.5-year programme starts in 2026 and focuses on developing bioprocess strategies and skeletal editing to create novel therapeutic nucleosides, integrating synthesis, analytics, and biocatalysis within a collaborative research environment.

#J-18808-Ljbffr